Nan Fung Group Holdings’s Harmony Biosciences HRMY Stock Holding History

Nan Fung Group Holdings’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$758K	Hold	27,049	–	–	0.62%	20
2025 Q4	$1.01M	Hold	27,049	–	–	0.91%	19
2025 Q3	$745K	Sell	27,049 -341,616	-93%	-$11.8M	1.25%	18
2025 Q2	$11.6M	Hold	368,665	–	–	18.37%	1
2025 Q1	$12.2M	Hold	368,665	–	–	9.98%	1
2024 Q4	$12.7M	Hold	368,665	–	–	10.85%	2
2024 Q3	$14.7M	Hold	368,665	–	–	12.7%	2
2024 Q2	$11.1M	Hold	368,665	–	–	11.87%	2
2024 Q1	$12.4M	Hold	368,665	–	–	11.47%	2
2023 Q4	$11.9M	Hold	368,665	–	–	7.42%	3
2023 Q3	$12.1M	Hold	368,665	–	–	9.78%	3
2023 Q2	$13M	Hold	368,665	–	–	8.29%	3
2023 Q1	$12M	Hold	368,665	–	–	8.19%	3
2022 Q4	$20.3M	Sell	368,665 -142,313	-28%	-$7.82M	14%	3
2022 Q3	$22.6M	Sell	510,978 -125,000	-20%	-$6.1M	14.44%	3
2022 Q2	$31M	Sell	635,978 -132,730	-17%	-$5.98M	21.3%	1
2022 Q1	$37.4M	Hold	768,708	–	–	17.74%	2
2021 Q4	$32.8M	Hold	768,708	–	–	9.7%	3
2021 Q3	$29.5M	Hold	768,708	–	–	9.43%	3
2021 Q2	$21.7M	Buy	+768,708	New	+$23.1M	6.74%	4

Other funds holding HRMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Nan Fung Group Holdings's HRMY Position: Q1 2026 in Review

Nan Fung Group Holdings held its Harmony Biosciences (HRMY) position steady in Q1 2026 at 27,049 shares worth $758K. The position accounts for 0.62% of the portfolio, ranked #20.

Nan Fung Group Holdings first reported a position in HRMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $37.4M in Q1 2022. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

Nan Fung Group Holdings held 27,049 shares of Harmony Biosciences worth $758K as of Q1 2026.
Nan Fung Group Holdings left its Harmony Biosciences share count unchanged in Q1 2026.
Harmony Biosciences made up 0.62% of Nan Fung Group Holdings's portfolio in Q1 2026, its #20 holding.
Nan Fung Group Holdings first reported a position in Harmony Biosciences in Q2 2021 and has held it in 20 quarters since.
Nan Fung Group Holdings's Harmony Biosciences position peaked at $37.4M in Q1 2022.
309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Nan Fung Group Holdings's 13F filing for Q1 2026, filed 14 May 2026.